Leukemia Research

Papers
(The H4-Index of Leukemia Research is 15. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2022-05-01 to 2026-05-01.)
ArticleCitations
Editorial Board25
THE TITO BASTIANELLO AND MDSF YOUNG INVESTIGATORS AWARDS23
GUIDED POSTER VIEWING SESSION 1: THERAPY - PART I20
Outcomes with high dose cytarabine and mitoxantrone induction for adults with mixed phenotype acute leukemia19
MDSF - EHA JOINT SESSION19
Editorial Board18
SOX11 AND EPSTEIN–BARR VIRUS MAY SUBSTITUTE EACH OTHER IN EARLY PATHOGENESIS OF BURKITT LYMPHOMA17
TARGETED THERAPY INCREASES PD-L1 PROTEIN EXPRESSION IN CELL LINES OF MEDIASTINAL LYMPHOMA17
DONOR-DERIVED B-LYMPHOBLASTIC LYMPHOMA FOLLOWING RENAL TRANSPLANT: A CASE REPORT16
ASSEMBLING A RARE NON-HODGKIN LYMPHOMA COHORT: EARLY FINDINGS FROM “THE UMBRELLA STUDY”16
Exploring the pathogenesis of extranodal natural killer/T cell lymphoma complicated With EBV via microarray data analysis16
Topic: AS04-MDS Biology and Pathogenesis/AS04h-Immune deregulation/inflammation: HIGHER LEPTIN LEVEL IS ASSOCIATED WITH MYELODYSPLASTIC SYNDROME: A COMPARATIVE STUDY16
Topic: AS04-MDS Biology and Pathogenesis/AS04a-Normal, MDS, and leukemic stem cells: DER(1;7)(Q10;P10) DEFINES A DISTINCT SUBTYPE OF MYELODYSPLASIA15
EFFICACY AND SAFETY OF SEQUENTIAL DIFFERENT B CELL ANTIGEN-TARGETED CAR T-CELL THERAPY FOR PEDIATRIC REFRACTORY/ RELAPSED BURKITT LYMPHOMA WITH SECONDARY CENTRAL NERVOUS SYSTEM INVOLVEMENT15
Topic: AS01-Diagnosis/AS01a-Cytomorphology: ARTIFICIAL INTELLIGENCE MAY HELP THE HEMATOPATHOLOGIST IN EVALUATION OF BONE MASS AND CELLULARITY IN BONE MARROW SPECIMENS OF PATIENTS WITH MDS15
5-AZACYTIDINE IN COMBINATION WITH A NOVEL PAN-LYSYL OXIDASE INHIBITOR SYNERGISTICALLY RESTORES ERYTHROPOIESIS IN MYELODYSPLASTIC MALIGNANCIES15
0.12477707862854